We focus on early stage investments in disruptive scientific and technological innovation.
Our portfolio boasts over 300 active patents covering world-changing innovations. We back the teams we believe are best able to deploy revolutionary technologies.
We have board representation at over 80% of our portfolio companies. We're committed to working alongside our founders to commercialize scientific discovery.
Our portfolio companies have collectively raised over two billion dollars. We invest across the life cycle of a company from pre-seed to pre-IPO.